Krystal Biotech (KRYS) News Today $148.39 +3.58 (+2.47%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 8.9% in DecemberKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 3,370,000 shares, a drop of 8.9% from the December 15th total of 3,700,000 shares. Based on an average daily volume of 247,300 shares, the short-interest ratio is currently 13.6 days.January 18 at 1:38 AM | marketbeat.comKrystal Biotech appoints Saxena as CFOJanuary 14, 2025 | markets.businessinsider.comJeune Aesthetics Appoints Nishant Saxena as Chief Financial OfficerJanuary 14, 2025 | globenewswire.comJPMorgan Chase & Co. Has $23.28 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)JPMorgan Chase & Co. reduced its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 21.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 127,901 shares of the company's stock after selling 35January 9, 2025 | marketbeat.comPositive Report for Erasca (ERAS) from Bank of America SecuritiesJanuary 7, 2025 | markets.businessinsider.comKrystal Biotech, Inc. (KRYS) Stock ForecastsJanuary 1, 2025 | finance.yahoo.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of "Buy" by AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has received a consensus recommendation of "Buy" from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, six have issued a buy recommendatJanuary 1, 2025 | marketbeat.comKuehn Law Encourages Investors of Krystal Biotech, Inc. to Contact Law FirmDecember 28, 2024 | markets.businessinsider.comKrystal Biotech: Blockbuster Ambitions For Topical Gene TherapyDecember 27, 2024 | seekingalpha.comPrincipal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Principal Financial Group Inc. trimmed its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 3.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 119,726 shares of thDecember 26, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?December 23, 2024 | uk.finance.yahoo.comKrystal Biotech’s Promising Clinical Advancements and Strategic Outlook Support Buy RatingDecember 19, 2024 | markets.businessinsider.comGeode Capital Management LLC Boosts Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Geode Capital Management LLC lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 591,631 shares of the company's stDecember 19, 2024 | marketbeat.comKrystal Biotech early lung cancer data ‘promising,’ says H.C. WainwrightDecember 19, 2024 | markets.businessinsider.comHere's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth TodayDecember 19, 2024 | benzinga.comKrystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at Chardan CapitalChardan Capital reaffirmed a "buy" rating and set a $212.00 price target on shares of Krystal Biotech in a research note on Wednesday.December 18, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Shares Gap Up - Still a Buy?Krystal Biotech (NASDAQ:KRYS) Shares Gap Up - Here's What HappenedDecember 18, 2024 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $221.00 price objective on shares of Krystal Biotech in a report on Wednesday.December 18, 2024 | marketbeat.comKrystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung CancerDecember 18, 2024 | globenewswire.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Franklin Resources Inc.Franklin Resources Inc. grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 34.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 243,760 shares of the company's sDecember 18, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Increases Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Teachers Retirement System of The State of Kentucky increased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 198.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,010 sDecember 18, 2024 | marketbeat.comLord Abbett & CO. LLC Has $51.73 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Lord Abbett & CO. LLC reduced its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 27.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 284,159 shares of the company's stock after selling 1December 15, 2024 | marketbeat.comSuma Krishnan Sells 25,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) StockKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) insider Suma Krishnan sold 25,000 shares of the company's stock in a transaction on Friday, December 13th. The shares were sold at an average price of $164.78, for a total transaction of $4,119,500.00. Following the completion of the sale, the insider now owns 1,475,882 shares of the company's stock, valued at approximately $243,195,835.96. This trade represents a 1.67 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.December 13, 2024 | marketbeat.comOptimistic Buy Rating for Krystal Biotech Driven by Promising Clinical Findings in Respiratory PlatformDecember 13, 2024 | markets.businessinsider.comKrystal Biotech Reports Promising Results for Genetic MedicineDecember 12, 2024 | markets.businessinsider.comPositive Outlook for Krystal Biotech: Regulatory Advancements and Promising Pipeline Drive Buy RatingDecember 11, 2024 | markets.businessinsider.comState Street Corp Has $264.46 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)State Street Corp grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,452,811 shares of the company's stock after purchasing an additional 119,December 11, 2024 | marketbeat.comKrystal Biotech announces no major objections from CHMP on B-VEC approvalDecember 10, 2024 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for Krystal Biotech (NASDAQ:KRYS)HC Wainwright restated a "buy" rating and set a $221.00 price target on shares of Krystal Biotech in a research note on Tuesday.December 10, 2024 | marketbeat.comKrystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis BullosaDecember 10, 2024 | markets.businessinsider.comKrystal Biotech Provides Update on EMA's Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis BullosaDecember 9, 2024 | globenewswire.comMain Management ETF Advisors LLC Buys New Shares in Krystal Biotech, Inc. (NASDAQ:KRYS)Main Management ETF Advisors LLC bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,880 shares of the company's stock, valued at approximately $December 8, 2024 | marketbeat.comBNP Paribas Financial Markets Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS)BNP Paribas Financial Markets boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 346.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,433 shares of the company's stock after acquiring an additional 8,0December 8, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by BrokeragesKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has earned an average rating of "Buy" from the eight ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and oneDecember 7, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company decreased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 23.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,225 shares of theDecember 6, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Redmile Group LLC's Largest PositionRedmile Group LLC lowered its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 20.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 810,245 shares of the company's stock after selliDecember 5, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 10.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 224,945 shaDecember 4, 2024 | marketbeat.comErste Asset Management GmbH Buys Shares of 18,200 Krystal Biotech, Inc. (NASDAQ:KRYS)Erste Asset Management GmbH purchased a new position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 18,200 shares of the company's stock, valued at approximatelDecember 3, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Charles Schwab Investment Management Inc. increased its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 240,216 shares of the company's stock after buying an additional 19,77December 2, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by Citigroup Inc.Citigroup Inc. increased its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 65.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,084 shares of the company'sDecember 1, 2024 | marketbeat.comBraidwell LP Acquires 61,512 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Braidwell LP boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 57.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 168,691 shares of the company's stock after acquiring aNovember 29, 2024 | marketbeat.comEventide Asset Management LLC Sells 40,704 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Eventide Asset Management LLC lessened its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 29.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 95,781 shares of the company's stock after selling 40,70November 29, 2024 | marketbeat.comFmr LLC Boosts Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Fmr LLC grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 0.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,292,881 shares of the company's stock after buying an additional 9,115 shares during the quartNovember 28, 2024 | marketbeat.comKrystal Biotech to Present at Upcoming Investor ConferencesNovember 27, 2024 | globenewswire.comIntech Investment Management LLC Purchases Shares of 7,270 Krystal Biotech, Inc. (NASDAQ:KRYS)Intech Investment Management LLC acquired a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 7,270 shares of the company's stock, valued at approximateNovember 27, 2024 | marketbeat.comSwiss National Bank Grows Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Swiss National Bank lifted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 8.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,100 shares of the company's stock afterNovember 26, 2024 | marketbeat.comSummit Trail Advisors LLC Invests $1.89 Million in Krystal Biotech, Inc. (NASDAQ:KRYS)Summit Trail Advisors LLC acquired a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,401 shares of the company's stock, valued at approximately $1,893,00November 25, 2024 | marketbeat.comEagle Asset Management Inc. Reduces Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Eagle Asset Management Inc. trimmed its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 16.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,602 shares of the company's stockNovember 24, 2024 | marketbeat.comJennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Jennison Associates LLC decreased its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 21.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 410,057 shares of the company's stock after selling 110,333 shares duringNovember 21, 2024 | marketbeat.comSegall Bryant & Hamill LLC Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Segall Bryant & Hamill LLC lifted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 352.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 157,144 shares of the company's stockNovember 20, 2024 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.570.44▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼35▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News GMAB News VTRS News ITCI News MRNA News RDY News CTLT News SRPT News PCVX News QGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump secret stock already up 339% In this video, you’ll also get nine other Trump-connected investments… All of which we believe could have a...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
